News & Updates

Vaginal micronized progesterone lowers risk of hypertensive disorders of pregnancy

23 Nov 2023

Initiation of vaginal micronized progesterone during the first trimester appears to reduce the risk of hypertensive disorders of pregnancy (HDP) and pre-eclampsia, according to a study.

Vaginal micronized progesterone lowers risk of hypertensive disorders of pregnancy

23 Nov 2023

8-week TAF course enough to prevent mother–child HBV transmission

20 Nov 2023 by

An 8-week course is as good as a 12-week course of tenofovir alafenamide fumarate (TAF) therapy in terms of preventing the transmission of hepatitis B virus (HBV) infection from mothers to infants, as reported in a study.

8-week TAF course enough to prevent mother–child HBV transmission

20 Nov 2023

Paternal age matters little in assisted reproduction

20 Nov 2023

For couples seeking to conceive via assisted reproduction, advanced age for male partners does not appear to lower the chances of being a parent, according to a study.

Paternal age matters little in assisted reproduction

20 Nov 2023

Experts share essential updates on COVID-19 vaccines

20 Nov 2023 by

SARS-CoV-2 continues to evolve into newer variants. Post-Delta, these variants are generally more highly transmissible and immune-evasive, although not more virulent, said Dr Gregory Poland, Mary Lowell Leary Emeritus Professor of Medicine and director of Mayo Vaccine Research Group, Mayo Clinic in Rochester, Minnesota, US, at IDWeek 2023.

Experts share essential updates on COVID-19 vaccines

20 Nov 2023

COVID-19 vaccination during pregnancy protects babies against Omicron infection

17 Nov 2023 by

Receiving an mRNA vaccine during pregnancy appears to put newborns at low risk of SARS-CoV-2 infection with the Omicron variant through 6 months of age, according to a study from Singapore.

COVID-19 vaccination during pregnancy protects babies against Omicron infection

17 Nov 2023

Vaginal vs laparoscopic hysterectomy shortens recovery time at expense of greater postoperative pain

16 Nov 2023

In the treatment of benign gynaecologic conditions, vaginal hysterectomy is associated with shorter total operative and recovery time compared with laparoscopic hysterectomy but has the disadvantage of greater postoperative pain, according to a study.

Vaginal vs laparoscopic hysterectomy shortens recovery time at expense of greater postoperative pain

16 Nov 2023

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

New drug applications approved by US FDA as of 01-15 November 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023 by

Induction chemotherapy followed by chemoradiotherapy (CRT) significantly improves progression-free survival (PFS) and overall survival (OS) in patients with locally advanced cervical cancer compared with standard CRT alone, according to the INTERLACE trial presented at ESMO 2023.

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

10 Nov 2023 by

Treatment with datopotamab deruxtecan (Dato-DXd), an investigational TROP2*-directed antibody-drug conjugate, significantly improves progression-free survival (PFS) in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer, according to the TROPION-Breast01 trial presented at ESMO 2023.

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

10 Nov 2023

Adding pembrolizumab to cCRT ups PFS in high-risk locally advanced cervical cancer

06 Nov 2023 by

In patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, adding pembrolizumab to concurrent chemoradiotherapy (cCRT) significantly improves progression-free survival (PFS) vs cCRT alone, according to results of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study presented at European Society for Medical Oncology Congress 2023 (ESMO 2023).

Adding pembrolizumab to cCRT ups PFS in high-risk locally advanced cervical cancer

06 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Vaginal micronized progesterone lowers risk of hypertensive disorders of pregnancy

Vaginal micronized progesterone lowers risk of hypertensive disorders of pregnancy

8-week TAF course enough to prevent mother–child HBV transmission

8-week TAF course enough to prevent mother–child HBV transmission

Paternal age matters little in assisted reproduction

Paternal age matters little in assisted reproduction

Experts share essential updates on COVID-19 vaccines

Experts share essential updates on COVID-19 vaccines

COVID-19 vaccination during pregnancy protects babies against Omicron infection

COVID-19 vaccination during pregnancy protects babies against Omicron infection

Vaginal vs laparoscopic hysterectomy shortens recovery time at expense of greater postoperative pain

Vaginal vs laparoscopic hysterectomy shortens recovery time at expense of greater postoperative pain

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

Adding pembrolizumab to cCRT ups PFS in high-risk locally advanced cervical cancer

Adding pembrolizumab to cCRT ups PFS in high-risk locally advanced cervical cancer